{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "Monanchora n. sp.", "antiviral", "crambescidins", "crambescins", "cytotoxicity", "docking", "guanidine alkaloids", "virtual screening"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33808721", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "22"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "19"}], "Language": ["eng"], "ELocationID": ["460", "10.3390/biom11030460"], "Journal": {"ISSN": "2218-273X", "JournalIssue": {"Volume": "11", "Issue": "3", "PubDate": {"Year": "2021", "Month": "Mar", "Day": "19"}}, "Title": "Biomolecules", "ISOAbbreviation": "Biomolecules"}, "ArticleTitle": "Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).", "Abstract": {"AbstractText": ["The huge global expansion of the COVID-19 pandemic caused by the novel SARS-corona virus-2 is an extraordinary public health emergency. The unavailability of specific treatment against SARS-CoV-2 infection necessitates the focus of all scientists in this direction. The reported antiviral activities of guanidine alkaloids encouraged us to run a comprehensive in silico binding affinity of fifteen guanidine alkaloids against five different proteins of SARS-CoV-2, which we investigated. The investigated proteins are COVID-19 main protease (M<sup>pro</sup>) (PDB ID: 6lu7), spike glycoprotein (PDB ID: 6VYB), nucleocapsid phosphoprotein (PDB ID: 6VYO), membrane glycoprotein (PDB ID: 6M17), and a non-structural protein (nsp10) (PDB ID: 6W4H). The binding energies for all tested compounds indicated promising binding affinities. A noticeable superiority for the pentacyclic alkaloids particularly, crambescidin 786 (<b>5</b>) and crambescidin 826 (<b>13</b>) has been observed. Compound <b>5</b> exhibited very good binding affinities against Mpro (\u0394G = -8.05 kcal/mol), nucleocapsid phosphoprotein (\u0394G = -6.49 kcal/mol), and nsp10 (\u0394G = -9.06 kcal/mol). Compound <b>13</b> showed promising binding affinities against M<sup>pro</sup> (\u0394G = -7.99 kcal/mol), spike glycoproteins (\u0394G = -6.95 kcal/mol), and nucleocapsid phosphoprotein (\u0394G = -8.01 kcal/mol). Such promising activities might be attributed to the long \u03c9-fatty acid chain, which may play a vital role in binding within the active sites. The correlation of c Log P with free binding energies has been calculated. Furthermore, the SAR of the active compounds has been clarified. The Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) studies were carried out in silico for the 15 compounds; most examined compounds showed optimal to good range levels of ADMET aqueous solubility, intestinal absorption and being unable to pass blood brain barrier (BBB), non-inhibitors of CYP2D6, non-hepatotoxic, and bind plasma protein with a percentage less than 90%. The toxicity of the tested compounds was screened in silico against five models (FDA rodent carcinogenicity, carcinogenic potency TD<sub>50</sub>, rat maximum tolerated dose, rat oral LD<sub>50</sub>, and rat chronic lowest observed adverse effect level (LOAEL)). All compounds showed expected low toxicity against the tested models. Molecular dynamic (MD) simulations were also carried out to confirm the stable binding interactions of the most promising compounds, <b>5</b> and <b>13,</b> with their targets. In conclusion, the examined 15 alkaloids specially <b>5</b> and <b>13</b> showed promising docking, ADMET, toxicity and MD results which open the door for further investigations for them against SARS-CoV-2."]}, "AuthorList": [{"Identifier": ["0000-0001-6459-2955"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic Biology & Biological Chemistry Department, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, UK."}, {"Identifier": [], "Affiliation": "Organic Chemistry Division, Chemistry Department, Faculty of Science, Mansoura University, Mansoura 35516, Egypt."}], "LastName": "El-Demerdash", "ForeName": "Amr", "Initials": "A"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy & Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Design and Discovery Lab, Zewail City of Science and Technology, Giza 12578, Egypt."}, {"Identifier": [], "Affiliation": "Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza 12578, Egypt."}], "LastName": "Hassan", "ForeName": "Afnan", "Initials": "A"}, {"Identifier": ["0000-0002-3441-9673"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA."}, {"Identifier": [], "Affiliation": "Zoology Department, Faculty of Science, Minia University, El-Minia 61519, Egypt."}], "LastName": "Abd El-Aziz", "ForeName": "Tarek Mohamed", "Initials": "TM"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, AlMaarefa University, Ad Diriyah 13713, Riyadh, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Drug Design and Discovery Lab, Zewail City of Science and Technology, Giza 12578, Egypt."}, {"Identifier": [], "Affiliation": "Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza 12578, Egypt."}], "LastName": "Arafa", "ForeName": "Reem K", "Initials": "RK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cellular and Integrative Physiology, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229-3900, USA."}], "LastName": "Stockand", "ForeName": "James D", "Initials": "JD"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Biomolecules", "NlmUniqueID": "101596414", "ISSNLinking": "2218-273X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Coronavirus Nucleocapsid Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Spike Glycoprotein, Coronavirus"}, {"RegistryNumber": "0", "NameOfSubstance": "nucleocapsid phosphoprotein, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "spike protein, SARS-CoV-2"}, {"RegistryNumber": "EC 3.4.-", "NameOfSubstance": "Viral Proteases"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Alkaloids"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology", "toxicity"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Blood-Brain Barrier"}, {"QualifierName": ["chemistry"], "DescriptorName": "Coronavirus Nucleocapsid Proteins"}, {"QualifierName": [], "DescriptorName": "Crystallography, X-Ray"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": ["chemistry"], "DescriptorName": "Membrane Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Dynamics Simulation"}, {"QualifierName": ["chemistry"], "DescriptorName": "Phosphoproteins"}, {"QualifierName": ["chemistry"], "DescriptorName": "Porifera"}, {"QualifierName": ["chemistry"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["chemistry"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Software"}, {"QualifierName": ["chemistry"], "DescriptorName": "Spike Glycoprotein, Coronavirus"}, {"QualifierName": ["chemistry"], "DescriptorName": "Viral Proteases"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "El-Aziz T.M.A., Stockand J.D. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)\u2014An update on the status. Infect. Genet. Evol. 2020;83:104327. doi: 10.1016/j.meegid.2020.104327.", "ArticleIdList": ["10.1016/j.meegid.2020.104327", "PMC7166307", "32320825"]}, {"Citation": "Steffens I. A hundred days into the coronavirus disease (COVID-19) pandemic. Euro Surveill. 2020;25:2000550. doi: 10.2807/1560-7917.ES.2020.25.14.2000550.", "ArticleIdList": ["10.2807/1560-7917.ES.2020.25.14.2000550", "PMC7160442", "32290905"]}, {"Citation": "Fehr A.R., Perlman S. Coronaviruses: An overview of their replication and pathogenesis. Methods Mol. Biol. 2015;1282:1\u201323. doi: 10.1007/978-1-4939-2438-7_1.", "ArticleIdList": ["10.1007/978-1-4939-2438-7_1", "PMC4369385", "25720466"]}, {"Citation": "Weiss S.R., Navas-Martin S. Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol. Mol. Biol. Rev. 2005;69:635\u2013664. doi: 10.1128/MMBR.69.4.635-664.2005.", "ArticleIdList": ["10.1128/MMBR.69.4.635-664.2005", "PMC1306801", "16339739"]}, {"Citation": "Bradburne A.F., Tyrrell D.A. The propagation of \u201ccoronaviruses\u201d in tissue-culture. Arch Gesamte Virusforsch. 1969;28:133\u2013150. doi: 10.1007/BF01249379.", "ArticleIdList": ["10.1007/BF01249379", "PMC7086760", "4984061"]}, {"Citation": "Zumla A., Chan J.F., Azhar E.I., Hui D.S., Yuen K.Y. Coronaviruses\u2014Drug discovery and therapeutic options. Nat. Rev. Drug Discov. 2016;15:327\u2013347. doi: 10.1038/nrd.2015.37.", "ArticleIdList": ["10.1038/nrd.2015.37", "PMC7097181", "26868298"]}, {"Citation": "Su S., Wong G., Shi W., Liu J., Lai A.C.K., Zhou J., Liu W., Bi Y., Gao G.F. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol. 2016;24:490\u2013502. doi: 10.1016/j.tim.2016.03.003.", "ArticleIdList": ["10.1016/j.tim.2016.03.003", "PMC7125511", "27012512"]}, {"Citation": "Forni D., Cagliani R., Clerici M., Sironi M. Molecular Evolution of Human Coronavirus Genomes. Trends Microbiol. 2017;25:35\u201348. doi: 10.1016/j.tim.2016.09.001.", "ArticleIdList": ["10.1016/j.tim.2016.09.001", "PMC7111218", "27743750"]}, {"Citation": "Huang X., Dong W., Milewska A., Golda A., Qi Y., Zhu Q.K., Marasco W.A., Baric R.S., Sims A.C., Pyrc K., et al. Human Coronavirus HKU1 Spike Protein Uses O-Acetylated Sialic Acid as an Attachment Receptor Determinant and Employs Hemagglutinin-Esterase Protein as a Receptor-Destroying Enzyme. J. Virol. 2015;89:7202\u20137213. doi: 10.1128/JVI.00854-15.", "ArticleIdList": ["10.1128/JVI.00854-15", "PMC4473545", "25926653"]}, {"Citation": "Ge X.Y., Li J.L., Yang X.L., Chmura A.A., Zhu G., Epstein J.H., Mazet J.K., Hu B., Zhang W., Peng C., et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503:535\u2013538. doi: 10.1038/nature12711.", "ArticleIdList": ["10.1038/nature12711", "PMC5389864", "24172901"]}, {"Citation": "de Wit E., van Doremalen N., Falzarano D., Munster V.J. SARS and MERS: Recent insights into emerging coronaviruses. Nat. Rev. Microbiol. 2016;14:523\u2013534. doi: 10.1038/nrmicro.2016.81.", "ArticleIdList": ["10.1038/nrmicro.2016.81", "PMC7097822", "27344959"]}, {"Citation": "Ithete N.L., Stoffberg S., Corman V.M., Cottontail V.M., Richards L.R., Schoeman M.C., Drosten C., Drexler J.F., Preiser W. Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa. Emerg. Infect. Dis. 2013;19:1697\u20131699. doi: 10.3201/eid1910.130946.", "ArticleIdList": ["10.3201/eid1910.130946", "PMC3810765", "24050621"]}, {"Citation": "Pati\u00f1o-Galindo J.\u00c1., Filip I., AlQuraishi M., Rabadan R. Recombination and convergent evolution led to the emergence of 2019 Wuhan coronavirus. bioRxiv. 2020 doi: 10.1101/2020.02.10.942748.", "ArticleIdList": ["10.1101/2020.02.10.942748"]}, {"Citation": "Zhou P., Yang X.L., Wang X.G., Hu B., Zhang L., Zhang W., Si H.R., Zhu Y., Li B., Huang C.L., et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u2013273. doi: 10.1038/s41586-020-2012-7.", "ArticleIdList": ["10.1038/s41586-020-2012-7", "PMC7095418", "32015507"]}, {"Citation": "Ren L.L., Wang Y.M., Wu Z.Q., Xiang Z.C., Guo L., Xu T., Jiang Y.Z., Xiong Y., Li Y.J., Li X.W., et al. Identification of a novel coronavirus causing severe pneumonia in human: A descriptive study. Chin. Med J. 2020;133:1015\u20131024. doi: 10.1097/CM9.0000000000000722.", "ArticleIdList": ["10.1097/CM9.0000000000000722", "PMC7147275", "32004165"]}, {"Citation": "Rossmann M.G. Structure of viruses: A short history. Q. Rev. Biophys. 2013;46:133. doi: 10.1017/S0033583513000012.", "ArticleIdList": ["10.1017/S0033583513000012", "23889891"]}, {"Citation": "Lodish H., Berk A., Zipursky S.L., Matsudaira P., Baltimore D., Darnell J. Molecular Cell Biology. 4th ed. WH Freeman; New York, NY, USA: 2000. Viruses."}, {"Citation": "Pornillos O., Garrus J.E., Sundquist W.I. Mechanisms of enveloped RNA virus budding. Trends Cell Biol. 2002;12:569\u2013579. doi: 10.1016/S0962-8924(02)02402-9.", "ArticleIdList": ["10.1016/S0962-8924(02)02402-9", "12495845"]}, {"Citation": "Li X., Geng M., Peng Y., Meng L., Lu S. Molecular immune pathogenesis and diagnosis of COVID-19. J. Pharm. Anal. 2020;19:1\u20137. doi: 10.1016/j.jpha.2020.03.001.", "ArticleIdList": ["10.1016/j.jpha.2020.03.001", "PMC7104082", "32282863"]}, {"Citation": "Zhang L., Lin D., Sun X., Curth U., Drosten C., Sauerhering L., Becker S., Rox K., Hilgenfeld R. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved \u03b1-ketoamide inhibitors. Science. 2020;368:409\u2013412. doi: 10.1126/science.abb3405.", "ArticleIdList": ["10.1126/science.abb3405", "PMC7164518", "32198291"]}, {"Citation": "Prajapat M., Sarma P., Shekhar N., Avti P., Sinha S., Kaur H., Kumar S., Bhattacharyya A., Kumar H., Bansal S. Drug targets for corona virus: A systematic review. Indian J. Pharmacol. 2020;52:56.", "ArticleIdList": ["PMC7074424", "32201449"]}, {"Citation": "Bouvet M., Lugari A., Posthuma C.C., Zevenhoven J.C., Bernard S., Betzi S., Imbert I., Canard B., Guillemot J.-C., L\u00e9cine P. Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. J. Biol. Chem. 2014;289:25783\u201325796. doi: 10.1074/jbc.M114.577353.", "ArticleIdList": ["10.1074/jbc.M114.577353", "PMC4162180", "25074927"]}, {"Citation": "Bergmann W., Burke D.C. Contributions to the study of marine products. XXXIX. The nucleosides of sponges. III.1 Spongothymidine and spongouridine2. J. Org. Chem. 1955;20:1501\u20131507. doi: 10.1021/jo01128a007.", "ArticleIdList": ["10.1021/jo01128a007"]}, {"Citation": "Newman D.J., Cragg G.M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016;79:629\u2013661. doi: 10.1021/acs.jnatprod.5b01055.", "ArticleIdList": ["10.1021/acs.jnatprod.5b01055", "26852623"]}, {"Citation": "Dias D.A., Urban S., Roessner U. A Historical Overview of Natural Products in Drug Discovery. Metabolites. 2012;2:303\u2013336. doi: 10.3390/metabo2020303.", "ArticleIdList": ["10.3390/metabo2020303", "PMC3901206", "24957513"]}, {"Citation": "Mayer A.M.S., Glaser K.B., Cuevas C., Jacobs R.S., Kem W., Little R.D., McIntosh J.M., Newman D.J., Potts B.C., Shuster D.E. The odyssey of marine pharmaceuticals: A current pipeline perspective. Trends Pharm. Sci. 2010;31:255\u2013265. doi: 10.1016/j.tips.2010.02.005.", "ArticleIdList": ["10.1016/j.tips.2010.02.005", "20363514"]}, {"Citation": "Montaser R., Luesch H. Marine natural products: A new wave of drugs? Future Med. Chem. 2011;3:1475\u20131489. doi: 10.4155/fmc.11.118.", "ArticleIdList": ["10.4155/fmc.11.118", "PMC3210699", "21882941"]}, {"Citation": "Altmann K.-H. Drugs from the Oceans: Marine Natural Products as Leads for Drug Discovery. Chim. Int. J. Chem. 2017;71:646\u2013652. doi: 10.2533/chimia.2017.646.", "ArticleIdList": ["10.2533/chimia.2017.646", "29070409"]}, {"Citation": "Jim\u00e9nez C. Marine Natural Products in Medicinal Chemistry. ACS Med. Chem. Lett. 2018;9:959\u2013961. doi: 10.1021/acsmedchemlett.8b00368.", "ArticleIdList": ["10.1021/acsmedchemlett.8b00368", "PMC6187399", "30344898"]}, {"Citation": "Pereira F. Have marine natural product drug discovery efforts been productive and how can we improve their efficiency? Expert Opin. Drug Discov. 2019;14:717\u2013722. doi: 10.1080/17460441.2019.1604675.", "ArticleIdList": ["10.1080/17460441.2019.1604675", "30982363"]}, {"Citation": "Donia M., Hamann M.T. Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis. 2003;3:338\u2013348. doi: 10.1016/S1473-3099(03)00655-8.", "ArticleIdList": ["10.1016/S1473-3099(03)00655-8", "PMC7106398", "12781505"]}, {"Citation": "Williams D.E., Andersen R.J. Biologically active marine natural products and their molecular targets discovered using a chemical genetics approach. Nat. Prod. Rep. 2020;37:617\u2013633. doi: 10.1039/C9NP00054B.", "ArticleIdList": ["10.1039/C9NP00054B", "PMC7874888", "31750842"]}, {"Citation": "\u00c1lvarez-Bard\u00f3n M., P\u00e9rez-Pertejo Y., Ord\u00f3\u00f1ez C., Sep\u00falveda-Crespo D., Carballeira N.M., Tekwani B.L., Murugesan S., Martinez-Valladares M., Garc\u00eda-Estrada C., Reguera R.M., et al. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria. Mar. Drugs. 2020;18:187. doi: 10.3390/md18040187.", "ArticleIdList": ["10.3390/md18040187", "PMC7230869", "32244488"]}, {"Citation": "Khan M.T., Ali A., Wang Q., Irfan M., Khan A., Zeb M.T., Zhang Y.-J., Chinnasamy S., Wei D.-Q. Marine natural compounds as potents inhibitors against the main protease of SARS-CoV-2\u2014A molecular dynamic study. J. Biomol. Struct. Dyn. 2020 doi: 10.1080/07391102.2020.1769733.", "ArticleIdList": ["10.1080/07391102.2020.1769733", "PMC7284144", "32410504"]}, {"Citation": "Carroll A.R., Copp B.R., Davis R.A., Keyzers R.A., Prinsep M.R. Marine natural products. Nat. Prod. Rep. 2020;37:175\u2013223. doi: 10.1039/C9NP00069K.", "ArticleIdList": ["10.1039/C9NP00069K", "32025684"]}, {"Citation": "Yasuhara-Bell J., Lu Y. Marine compounds and their antiviral activities. Antivir. Res. 2010;86:231\u2013240. doi: 10.1016/j.antiviral.2010.03.009.", "ArticleIdList": ["10.1016/j.antiviral.2010.03.009", "PMC7132374", "20338196"]}, {"Citation": "Gogineni V., Schinazi R.F., Hamann M.T. Role of Marine Natural Products in the Genesis of Antiviral Agents. Chem. Rev. 2015;115:9655\u20139706. doi: 10.1021/cr4006318.", "ArticleIdList": ["10.1021/cr4006318", "PMC4883660", "26317854"]}, {"Citation": "El-Demerdash A., Atanasov A.G., Bishayee A., Abdel-Mogib M., Hooper J.N.A., Al-Mourabit A. Batzella, Crambe and Monanchora: Highly Prolific Marine Sponge Genera Yielding Compounds with Potential Applications for Cancer and Other Therapeutic Areas. Nutrients. 2018;10:33. doi: 10.3390/nu10010033.", "ArticleIdList": ["10.3390/nu10010033", "PMC5793261", "29301302"]}, {"Citation": "Sfecci E., Lacour T., Amade P., Mehiri M. Polycyclic Guanidine Alkaloids from Poecilosclerida Marine Sponges. Mar. Drugs. 2016;14:77. doi: 10.3390/md14040077.", "ArticleIdList": ["10.3390/md14040077", "PMC4849081", "27070629"]}, {"Citation": "El-Demerdash A., Tammam M.A., Atanasov A.G., Hooper J.N.A., Al-Mourabit A., Kijjoa A. Chemistry and Biological Activities of the Marine Sponges of the Genera Mycale (Arenochalina), Biemna and Clathria. Mar. Drugs. 2018;16:214. doi: 10.3390/md16060214.", "ArticleIdList": ["10.3390/md16060214", "PMC6025471", "29912171"]}, {"Citation": "Kashman Y., Hirsh S., McConnell O.J., Ohtani I., Kusumi T., Kakisawa H. Ptilomycalin A: A novel polycyclic guanidine alkaloid of marine origin. J. Am. Chem. Soc. 1989;111:8925\u20138926. doi: 10.1021/ja00206a029.", "ArticleIdList": ["10.1021/ja00206a029"]}, {"Citation": "El-Demerdash A., Ermolenko L., Gros E., Retailleau P., Thanh B.N., Anne G.-B., Al-Mourabit A. Short-Cut Bio-Inspired Synthesis of Tricyclic Guanidinic Motifs of Crambescidins and Batzelladines Marine Alkaloids. Eur. J. Org. Chem. 2020 doi: 10.1002/ejoc.202000744.", "ArticleIdList": ["10.1002/ejoc.202000744"]}, {"Citation": "Jares-Erijman E.A., Sakai R., Rinehart K.L. Crambescidins: New antiviral and cytotoxic compounds from the sponge Crambe crambe. J. Org. Chem. 1991;56:5712\u20135715. doi: 10.1021/jo00019a049.", "ArticleIdList": ["10.1021/jo00019a049"]}, {"Citation": "Rubiolo J.A., L\u00f3pez-Alonso H., Roel M., Vieytes M.R., Thomas O., Ternon E., Vega F.V., Botana L.M. Mechanism of cytotoxic action of crambescidin-816 on human liver-derived tumour cells. Br. J. Pharm. 2014;171:1655\u20131667. doi: 10.1111/bph.12552.", "ArticleIdList": ["10.1111/bph.12552", "PMC3966746", "24328908"]}, {"Citation": "El-Demerdash A., Moriou C., Martin M.-T., Rodrigues-Stien A.d.S., Petek S., Demoy-Schneider M., Hall K., Hooper J.N.A., Debitus C., Al-Mourabit A. Cytotoxic Guanidine Alkaloids from a French Polynesian Monanchora n. sp. Sponge. J. Nat. Prod. 2016;79:1929\u20131937. doi: 10.1021/acs.jnatprod.6b00168.", "ArticleIdList": ["10.1021/acs.jnatprod.6b00168", "27419263"]}, {"Citation": "El-Demerdash A., Moriou C., Martin M.-T., Petek S., Debitus C., Al-Mourabit A. Unguiculins A-C: Cytotoxic bis-guanidine alkaloids from the French Polynesian sponge, Monanchora n. sp. Nat. Prod. Res. 2018;32:1512\u20131517. doi: 10.1080/14786419.2017.1385011.", "ArticleIdList": ["10.1080/14786419.2017.1385011", "29067835"]}, {"Citation": "Mendez A.G., Juncal A.B., Silva S.B.L., Thomas O.P., Mart\u00edn V\u00e1zquez V., Alfonso A., Vieytes M.R., Vale C., Botana L.M. The Marine Guanidine Alkaloid Crambescidin 816 Induces Calcium Influx and Cytotoxicity in Primary Cultures of Cortical Neurons through Glutamate Receptors. ACS Chem. Neurosci. 2017;8:1609\u20131617. doi: 10.1021/acschemneuro.7b00096.", "ArticleIdList": ["10.1021/acschemneuro.7b00096", "28375602"]}, {"Citation": "Shrestha S., Sorolla A., Fromont J., Blancafort P., Flematti G.R. Crambescidin 800, Isolated from the Marine Sponge Monanchora viridis, Induces Cell Cycle Arrest and Apoptosis in Triple-Negative Breast Cancer Cells. Mar. Drugs. 2018;16:53. doi: 10.3390/md16020053.", "ArticleIdList": ["10.3390/md16020053", "PMC5852481", "29419736"]}, {"Citation": "Shubina L.K., Makarieva T.N., von Amsberg G., Denisenko V.A., Popov R.S., Dyshlovoy S.A. Monanchoxymycalin C with anticancer properties, new analogue of crambescidin 800 from the marine sponge Monanchora pulchra. Nat. Prod. Res. 2019;33:1415\u20131422. doi: 10.1080/14786419.2017.1419231.", "ArticleIdList": ["10.1080/14786419.2017.1419231", "29272957"]}, {"Citation": "Palagiano E., De Marino S., Minale L., Riccio R., Zollo F., Iorizzi M., Carr\u00e9 J.B., Debitus C., Lucarain L., Provost J. Ptilomycalin A, crambescidin 800 and related new highly cytotoxic guanidine alkaloids from the starfishes Fromia monilis and Celerina heffernani. Tetrahedron. 1995;51:3675\u20133682. doi: 10.1016/0040-4020(95)00082-J.", "ArticleIdList": ["10.1016/0040-4020(95)00082-J"]}, {"Citation": "Amade P., Charroin C., Baby C., Vacelet J. Antimicrobial activities of marine sponges from the Mediterranean Sea. Mar. Biol. 1987;94:271\u2013275. doi: 10.1007/BF00392940.", "ArticleIdList": ["10.1007/BF00392940"]}, {"Citation": "Sun X., Sun S., Ference C., Zhu W., Zhou N., Zhang Y., Zhou K. A potent antimicrobial compound isolated from Clathria cervicornis. Bioorg. Med. Chem. Lett. 2015;25:67\u201369. doi: 10.1016/j.bmcl.2014.11.012.", "ArticleIdList": ["10.1016/j.bmcl.2014.11.012", "25435146"]}, {"Citation": "Rubiolo J.A., Ternon E., L\u00f3pez-Alonso H., Thomas O.P., Vega F.V., Vieytes M.R., Botana L.M. Crambescidin-816 Acts as a Fungicidal with More Potency than Crambescidin-800 and -830, Inducing Cell Cycle Arrest, Increased Cell Size and Apoptosis in Saccharomyces cerevisiae. Mar. Drugs. 2013;11:4419\u20134434. doi: 10.3390/md11114419.", "ArticleIdList": ["10.3390/md11114419", "PMC3853736", "24217285"]}, {"Citation": "Kasmiati K., Yoshioka Y., Okamoto T., Ojika M. New Crambescidin-Type Alkaloids from the Indonesian Marine Sponge Clathria bulbotoxa. Mar. Drugs. 2018;16:84. doi: 10.3390/md16030084.", "ArticleIdList": ["10.3390/md16030084", "PMC5867628", "29518039"]}, {"Citation": "Campos P.E., Ferreira Queiroz E., Marcourt L., Wolfender J.L., Sanchez A.S., Illien B., Al Mourabit A., Gauvin-Bialecki A. Isolation and identification of new secondary metabolites from the marine sponge Monanchora unguiculata. Planta Med. 2016;82:P580. doi: 10.1055/s-0036-1596641.", "ArticleIdList": ["10.1055/s-0036-1596641"]}, {"Citation": "Campos P.-E., Wolfender J.-L., Queiroz E.F., Marcourt L., Al-Mourabit A., Frederich M., Bordignon A., De Voogd N., Illien B., Gauvin-Bialecki A. Unguiculin A and Ptilomycalins E\u2013H, Antimalarial Guanidine Alkaloids from the Marine Sponge Monanchora unguiculata. J. Nat. Prod. 2017;80:1404\u20131410. doi: 10.1021/acs.jnatprod.6b01079.", "ArticleIdList": ["10.1021/acs.jnatprod.6b01079", "28368118"]}, {"Citation": "Lazaro J.E.H., Nitcheu J., Mahmoudi N., Ibana J.A., Mangalindan G.C., Black G.P., Howard-Jones A.G., Moore C.G., Thomas D.A., Mazier D., et al. Antimalarial Activity of Crambescidin 800 and Synthetic Analogues against Liver and Blood Stage of Plasmodium sp. J. Antibiot. 2006;59:583\u2013590. doi: 10.1038/ja.2006.78.", "ArticleIdList": ["10.1038/ja.2006.78", "17136890"]}, {"Citation": "Takishima S., Ishiyama A., Iwatsuki M., Otoguro K., Yamada H., Omura S., Kobayashi H., van Soest R.W., Matsunaga S. Merobatzelladines A and B, anti-infective tricyclic guanidines from a marine sponge Monanchora sp. Org. Lett. 2009;11:2655\u20132658. doi: 10.1021/ol9006794.", "ArticleIdList": ["10.1021/ol9006794", "19469518"]}, {"Citation": "Suna H., Aoki S., Setiawan A., Kobayashi M. Crambescidin 800, a pentacyclic guanidine alkaloid, protects a mouse hippocampal cell line against glutamate-induced oxidative stress. J. Nat. Med. 2007;61:288\u2013295. doi: 10.1007/s11418-007-0148-5.", "ArticleIdList": ["10.1007/s11418-007-0148-5"]}, {"Citation": "Nakao Y., Fusetani N. Enzyme Inhibitors from Marine Invertebrates. J. Nat. Prod. 2007;70:689\u2013710. doi: 10.1021/np060600x.", "ArticleIdList": ["10.1021/np060600x", "17362037"]}, {"Citation": "Mai S., Nagulapalli V., Patil A., Truneh A., Westley J. Marine Compounds as HIV Inhibitors. WO9301193 (A1) U.S. Patent Application. 1993 Jan 21;"}, {"Citation": "Patil A.D., Kumar N.V., Kokke W.C., Bean M.F., Freyer A.J., Brosse C.D., Mai S., Truneh A., Carte B. Novel alkaloids from the sponge Batzella sp.: Inhibitors of HIV gp120-human CD4 binding. J. Org. Chem. 1995;60:1182\u20131188. doi: 10.1021/jo00110a021.", "ArticleIdList": ["10.1021/jo00110a021"]}, {"Citation": "Bewley C.A., Ray S., Cohen F., Collins S.K., Overman L.E. Inhibition of HIV-1 Envelope-Mediated Fusion by Synthetic Batzelladine Analogues. J. Nat. Prod. 2004;67:1319\u20131324. doi: 10.1021/np049958o.", "ArticleIdList": ["10.1021/np049958o", "15332849"]}, {"Citation": "Rinehart K.L., Jares-Erijman E.A. Crambescidins: New Antiviral and Cytotoxic Compounds from the Sponge Crambe crambe. No. 5,756,734. U.S. Patent. 1998 May 26;"}, {"Citation": "Rinehart K.L., Shi J.-G., Sun F. Crambescidin Compounds. No. 6,028,077. U.S. Patent. 2000 Feb 22;"}, {"Citation": "Chang L., Whittaker N.F., Bewley C.A. Crambescidin 826 and Dehydrocrambine A:\u2009 New Polycyclic Guanidine Alkaloids from the Marine Sponge Monanchora sp. that Inhibit HIV-1 Fusion. J. Nat. Prod. 2003;66:1490\u20131494. doi: 10.1021/np030256t.", "ArticleIdList": ["10.1021/np030256t", "14640525"]}, {"Citation": "Gustafson K.R., Oku N., Milanowski D.J. Antiviral Marine Natural Products. Curr. Med. Chem. Anti-Infect. Agents. 2004;3:233\u2013249. doi: 10.2174/1568012043353919.", "ArticleIdList": ["10.2174/1568012043353919"]}, {"Citation": "Patil A.D., Freyer A.J., Taylor P.B., Cart\u00e9 B., Zuber G., Johnson R.K., Faulkner D.J. Batzelladines F\u2212I, Novel Alkaloids from the Sponge Batzella sp.: Inducers of p56lck-CD4 Dissociation. J. Org. Chem. 1997;62:1814\u20131819. doi: 10.1021/jo962084t.", "ArticleIdList": ["10.1021/jo962084t"]}, {"Citation": "Patil A.D., Freyer A.J., Offen P., Bean M.F., Johnson R.K. Three New Tricyclic Guanidine Alkaloids from the Sponge Batzella sp. J. Nat. Prod. 1997;60:704\u2013707. doi: 10.1021/np970014r.", "ArticleIdList": ["10.1021/np970014r"]}, {"Citation": "Olszewski A., Sato K., Aron Z.D., Cohen F., Harris A., McDougall B.R., Robinson W.E., Overman L.E., Weiss G.A. Guanidine alkaloid analogs as inhibitors of HIV-1 Nef interactions with p53, actin, and p56lck. Proc. Natl. Acad. Sci. USA. 2004;101:14079\u201314084. doi: 10.1073/pnas.0406040101.", "ArticleIdList": ["10.1073/pnas.0406040101", "PMC521092", "15371598"]}, {"Citation": "Hua H.-M., Peng J., Dunbar D.C., Schinazi R.F., de Castro Andrews A.G., Cuevas C., Garcia-Fernandez L.F., Kelly M., Hamann M.T. Batzelladine alkaloids from the Caribbean sponge Monanchora unguifera and the significant activities against HIV-1 and AIDS opportunistic infectious pathogens. Tetrahedron. 2007;63:11179\u201311188. doi: 10.1016/j.tet.2007.08.005.", "ArticleIdList": ["10.1016/j.tet.2007.08.005"]}, {"Citation": "Harvey A.L. Presynaptic effects of toxins. Int. Rev. Neurobiol. 1990;32:201\u2013239.", "ArticleIdList": ["1706687"]}, {"Citation": "El-Gamal K.M., El-Morsy A.M., Saad A.M., Eissa I.H., Alswah M. Synthesis, docking, QSAR, ADMET and antimicrobial evaluation of new quinoline-3-carbonitrile derivatives as potential DNA-gyrase inhibitors. J. Mol. Struct. 2018;1166:15\u201333. doi: 10.1016/j.molstruc.2018.04.010.", "ArticleIdList": ["10.1016/j.molstruc.2018.04.010"]}, {"Citation": "Li N., Wang Y., Li W., Li H., Yang L., Wang J., Mahdy H.A., Mehany A., Jaiash D.A., Santali E.Y. Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3. J. Chem. 2020;2020:1631243. doi: 10.1155/2020/1631243.", "ArticleIdList": ["10.1155/2020/1631243"]}, {"Citation": "Ibrahim M.K., Eissa I.H., Alesawy M.S., Metwaly A.M., Radwan M.M., ElSohly M.A. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of quinazolin-4 (3H)-one derivatives as potential PPAR\u03b3 and SUR agonists. Bioorganic Med. Chem. 2017;25:4723\u20134744. doi: 10.1016/j.bmc.2017.07.015.", "ArticleIdList": ["10.1016/j.bmc.2017.07.015", "28720328"]}, {"Citation": "Elmetwally S.A., Saied K.F., Eissa I.H., Elkaeed E.B. Design, synthesis and anticancer evaluation of thieno [2,3-d] pyrimidine derivatives as dual EGFR/HER2 inhibitors and apoptosis inducers. Bioorganic Chem. 2019;88:102944. doi: 10.1016/j.bioorg.2019.102944.", "ArticleIdList": ["10.1016/j.bioorg.2019.102944", "31051400"]}, {"Citation": "Mahdy H.A., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., El-Gamal K.M., El-Sharkawy A., Elhendawy M.A., Radwan M.M., Elsohly M.A. Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4 (3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Bioorganic Chem. 2020;94:103422. doi: 10.1016/j.bioorg.2019.103422.", "ArticleIdList": ["10.1016/j.bioorg.2019.103422", "31812261"]}, {"Citation": "El-Zahabi M.A., Elbendary E.R., Bamanie F.H., Radwan M.F., Ghareib S.A., Eissa I.H. Design, synthesis, molecular modeling and anti-hyperglycemic evaluation of phthalimide-sulfonylurea hybrids as PPAR\u03b3 and SUR agonists. Bioorganic Chem. 2019;91:103115. doi: 10.1016/j.bioorg.2019.103115.", "ArticleIdList": ["10.1016/j.bioorg.2019.103115", "31310882"]}, {"Citation": "El-Naggar A.M., Eissa I.H., Belal A., El-Sayed A.A. Design, eco-friendly synthesis, molecular modeling and anticancer evaluation of thiazol-5 (4 H)-ones as potential tubulin polymerization inhibitors targeting the colchicine binding site. RSC Adv. 2020;10:2791\u20132811. doi: 10.1039/C9RA10094F.", "ArticleIdList": ["10.1039/C9RA10094F", "PMC9048505", "35496078"]}, {"Citation": "Humphrey W., Dalke A., Schulten K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996;14:33\u201338. doi: 10.1016/0263-7855(96)00018-5.", "ArticleIdList": ["10.1016/0263-7855(96)00018-5", "8744570"]}, {"Citation": "Van De Waterbeemd H., Gifford E. ADMET in silico modelling: Towards prediction paradise? Nat. Rev. Drug Discov. 2003;2:192\u2013204. doi: 10.1038/nrd1032.", "ArticleIdList": ["10.1038/nrd1032", "12612645"]}, {"Citation": "Mannhold R., Kubinyi H., Folkers G. Pharmacokinetics and Metabolism in Drug Design. Volume 51 John Wiley & Sons; Hoboken, NJ, USA: 2012."}, {"Citation": "Klopman G., Stefan L.R., Saiakhov R.D. ADME evaluation: 2. A computer model for the prediction of intestinal absorption in humans. Eur. J. Pharm. Sci. 2002;17:253\u2013263. doi: 10.1016/S0928-0987(02)00219-1.", "ArticleIdList": ["10.1016/S0928-0987(02)00219-1", "12453615"]}, {"Citation": "Roy P.P., Roy K. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors. Chem. Biol. Drug Des. 2009;73:442\u2013455. doi: 10.1111/j.1747-0285.2009.00791.x.", "ArticleIdList": ["10.1111/j.1747-0285.2009.00791.x", "19291105"]}, {"Citation": "Ghafourian T., Amin Z. QSAR models for the prediction of plasma protein binding. Bioimpacts. 2013;3:21.", "ArticleIdList": ["PMC3648908", "23678466"]}, {"Citation": "Xia X., Maliski E.G., Gallant P., Rogers D. Classification of kinase inhibitors using a Bayesian model. J. Med. Chem. 2004;47:4463\u20134470. doi: 10.1021/jm0303195.", "ArticleIdList": ["10.1021/jm0303195", "15317458"]}, {"Citation": "BIOVIA  QSAR, ADMET and Predictive Toxicology.  [(accessed on 17 May 2020)]; Available online:  https://www.3dsbiovia.com/products/collaborative-science/biovia-discovery-studio/qsar-admet-and-predictive-toxicology.html."}, {"Citation": "Venkatapathy R., Wang N.C.Y., Martin T.M., Harten P.F., Young D. Structure\u2013Activity Relationships for Carcinogenic Potential. Gen. Appl. Syst. Toxicol. 2009 doi: 10.1002/9780470744307.gat079.", "ArticleIdList": ["10.1002/9780470744307.gat079"]}, {"Citation": "Goodrnan G., Wilson R. Comparison of the dependence of the TD50 on maximum tolerated dose for mutagens and nonmutagens. Risk Anal. 1992;12:525\u2013533. doi: 10.1111/j.1539-6924.1992.tb00709.x.", "ArticleIdList": ["10.1111/j.1539-6924.1992.tb00709.x", "1480798"]}, {"Citation": "Council N.R. Issues in Risk Assessment. National Academies Press (US); Cambridge, MA, USA: 1993. Correlation Between Carcinogenic Potency and the Maximum Tolerated Dose: Implications for Risk Assessment.", "ArticleIdList": ["8234946"]}, {"Citation": "Gonella Diaza R., Manganelli S., Esposito A., Roncaglioni A., Manganaro A., Benfenati E. Comparison of in silico tools for evaluating rat oral acute toxicity. Sar. Qsar. Environ. Res. 2015;26:1\u201327. doi: 10.1080/1062936X.2014.977819.", "ArticleIdList": ["10.1080/1062936X.2014.977819", "25567032"]}, {"Citation": "Pizzo F., Benfenati E. Silico Methods for Predicting Drug Toxicity. Springer; Berlin/Heidelberg, Germany: 2016. In silico models for repeated-dose toxicity (RDT): Prediction of the no observed adverse effect level (NOAEL) and lowest observed adverse effect level (LOAEL) for drugs; pp. 163\u2013176.", "ArticleIdList": ["27311467"]}, {"Citation": "Venkatapathy R., Moudgal C.J., Bruce R.M. Assessment of the oral rat chronic lowest observed adverse effect level model in TOPKAT, a QSAR software package for toxicity prediction. J. Chem. Inf. Comput. Sci. 2004;44:1623\u20131629. doi: 10.1021/ci049903s.", "ArticleIdList": ["10.1021/ci049903s", "15446819"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "5"}, {"Year": "2021", "Month": "3", "Day": "15"}, {"Year": "2021", "Month": "3", "Day": "16"}, {"Year": "2021", "Month": "4", "Day": "3", "Hour": "1", "Minute": "30"}, {"Year": "2021", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "23", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["33808721", "PMC8003478", "10.3390/biom11030460", "biom11030460"]}}], "PubmedBookArticle": []}